Sweden· SE-20050521000021
Competact 15 mg/850 mg Filmdragerad tablett
A medicinal product containing metformin hydrochloride + pioglitazone, registered in Sweden by Cheplapharm Arzneimittel GmbH.
Checked against Swedish Medical Products Agency (Sweden) on
Informational only — not a medical device.
The record
At a glance
Swedish Medical Products Agency (Sweden)- Active substance
- Metformin Hydrochloride + Pioglitazone
- Manufacturer
- Cheplapharm Arzneimittel GmbH
- Country
- Sweden (SE)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- Swedish Medical Products Agency (Sweden)
- Last checked
- October 1, 2026
Packs & prices · 1
- se_varunummer20050521000021
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Metformin hydrochloride + pioglitazone in 12 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesActoplus MetTakeda Pharmaceuticals America, Inc.
- United KingdomCompetact 15mg/850mg tabletsDE Pharmaceuticals
- ItalyCOMPETACTCHEPLAPHARM ARZNEIMITTEL GMBH
- SpainCOMPETACT 15 mg/850 mg COMPRIMIDOS RECUBIERTOS CON PELICULATakeda Pharma A/S
- CzechiaCOMPETACTCHEPLAPHARM Arzneimittel GmbH, Greifswald
- FinlandCompetactParanova Oy
- SwitzerlandCompetact
- IcelandCompetactCHEPLAPHARM Arzneimittel GmbH
Authorised across Europe · EMA
The same active substance is authorised in 12 EEA countries. Names it is sold under:
- Bulgaria · Пизона Комби
- Czechia · Novapio Plus
- Spain · Pioglitazona/Metformina Aristo
- United Kingdom (Northern Ireland) · Pioglitazone And Metformin Hydrochloride Clydesdale Pharma, Pioglitazone/Metformin Torrent Pharma (Uk)
- Greece · Pioglitazone/Metformin Genepharm
- Croatia · Novapio Plus
- Hungary · Pioglitazone / Metformin Genepharm
- Iceland · Competact
- Italy · Pioglitazone E Metformina Docgen, Pioglitazone E Metformina Eg
- Liechtenstein · Competact
- Norway · Competact
- Portugal · Metformina + Pioglitazona Biofarmoz, Metformina + Pioglitazona Farmoz
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swedish Medical Products Agency (Sweden). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/96b765a1-8dfc-467a-8ad5-a752d7f24947 GET /v1/drugs/96b765a1-8dfc-467a-8ad5-a752d7f24947?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"source": "lakemedelsverket",
"doc_types": [
"EPAR",
"EMA"
],
"se_npl_id": "20050521000021",
"product_page": "https://www.lakemedelsverket.se/sv/sok-lakemedelsfakta/lakemedel?id=20050521000021",
"product_doc_link": "https://www.ema.europa.eu/sv/documents/product-information/competact-epar-product-information_sv.pdf"
}See everything about metformin hydrochloride + pioglitazone.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.